Clotrimazole‐loaded PLGA microparticles for local drug delivery to the vagina: Shape does matter
Animal Models and Experimental Medicine · Published 2026-04-01 · DOI 10.1002/ame2.70198
Free full text
Authors being retrieved — see the publisher record. https://doi.org/10.1002/ame2.70198
Abstract
Abstract Background Intravaginal drug administration is the most promising strategy for treating vaginal infections to protect women's health, such as vulvovaginal candidiasis (VVC). However, conventional vaginal formulations in the clinic face challenges such as drug leakage and low bioavailability due to the mucus barrier and vaginal self‐cleaning behavior. To address these limitations, we designed and optimized clotrimazole‐loaded PLGA non‐spherical microparticles (CPNMs) for vaginal drug delivery. Methods CPNMs and clotrimazole‐loaded PLGA porous microspheres (CPMs) were prepared by the double emulsion‐solvent evaporation method. The physicochemical features and in vitro drug release kinetics were characterized, and the effect of shape on drug delivery were also investigated. After intravaginal administration of CPMs and CPNMs, the pharmacokinetics and biocompatibility in the vagina of mice were studied. Results Both CPMs and CPNMs exhibited sustained release features in vitro. Initially, there was a rapid release within the first 24 h and the cumulative release of CPMs and CPNMs was 46.55% and 56.89% over 7 days, respectively. Compared to CPMs, CPNMs demonstrated an extended drug release in vivo, maintaining a residence duration of at least 72 h, which was beneficial for clotrimazole delivery at a high concentration in the vagina of mice. Histological evaluation demonstrated the low cytotoxicity and good biocompatibility of CPNMs, with no obvious damage to vaginal epithelial cells. Conclusion This vaginal drug delivery system offers potential applications for managing VVC, along with other health concerns in women.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Publication details
- Year
- 2026
Related articles
- A mouse model of mechanical stress injury to the basal ganglia using thermosensitive PNIPAM hydrogel for intracerebral hemorrhage research · Animal Models and Experimental Medicine · 2026 · Same journal
- Mechanistic investigation of Liujing Toutong tablet in the treatment of cerebral ischemia–reperfusion injury in rats by the integration of serum pharmacochemistry and metabolomics · Animal Models and Experimental Medicine · 2026 · Same journal
- Strategies for inducing diabetes in laboratory animals: Advances from chemical, surgical, immunologic, dietary, and genetic approaches · Animal Models and Experimental Medicine · 2026 · Same journal
- A novel mouse model of chronic Pseudomonas aeruginosa infection inducing bronchiectasis‐like phenotype · Animal Models and Experimental Medicine · 2026 · Same journal
- ApoE ‐ and Cfh‐deficient mice exhibit structural and molecular features of human early–intermediate retinal degeneration · Animal Models and Experimental Medicine · 2026 · Same journal
- Stem cell–based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection · Animal Models and Experimental Medicine · 2026 · Same journal
- Cell therapy comparison of dental pulp stem cells, hepatocytes, and their exosomes for liver fibrosis treatment in rats · Animal Models and Experimental Medicine · 2026 · Same journal
- Chronic alcohol consumption compromises gut barrier integrity and promotes endotoxemia: Implications for sepsis susceptibility in immunocompromised hosts · Animal Models and Experimental Medicine · 2026 · Same journal
- USB1 deficiency disrupts neutrophil maturation via RNA dysregulation independent of global pre‐ mRNA splicing · Animal Models and Experimental Medicine · 2026 · Same journal
- Time‐course characterization of intraocular pressure in murine steroid‐induced ocular hypertension: Effects of route, schedule, and concentration · Animal Models and Experimental Medicine · 2026 · Same journal